Vivere Oncotherapies

Unlock the Full Potential of Cancer Immunotherapy

Berkeley, United States · $10.0M raised

Headquarters
Berkeley
Employees
1–10
Business Model
B2B
Total Funding
$10.0M
Last Round
$10.0M SeedJan 2026
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Vivere is developing next-generation cancer therapies aimed at activating the immune system to selectively detect and destroy cancer cells in cold tumors that otherwise remain hidden to the body’s natural defenses. Vivere’s team of scientists uses a proprietary bioengineering platform to design safe, targeted and more effective cancer-fighting therapies that deliver treatment more efficiently to where it’s needed most. The company’s vision is to unmask cold tumors to the immune system through improved delivery of targeted, safe, and effective therapies. This platform is based on over 25 years of academic and industry research and leverages technology developed at UC Berkeley.

Summary

Vivere Oncotherapies is a Biotech company based in Berkeley, United States. It has raised $10.0M in total across 1 round, most recently a $10.0M Seed round in Jan 2026. Investors include YK Bioventures, Freeflow Ventures and Pillar VC.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundJan 2026
$10.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vivere Oncotherapies on Indexed.vc
<a href="https://indexed.vc/companies/vivere-oncotherapies"><img src="https://indexed.vc/api/badge/company/vivere-oncotherapies" alt="Vivere Oncotherapies on Indexed.vc" width="260" height="76" /></a>